Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.

[1]  C. Ohyama,et al.  Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study , 2021, BJU international.

[2]  Cheryl T. Lee,et al.  Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival times. , 2021, Urologic oncology.

[3]  Steven L. Chang,et al.  Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. , 2020, European urology.

[4]  S. Shariat,et al.  Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis , 2020, International Journal of Clinical Oncology.

[5]  J. Donovan,et al.  Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial , 2020, The Lancet.

[6]  S. Park,et al.  Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03 , 2019, Cancer medicine.

[7]  M. Babjuk,et al.  Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer. , 2017, European urology focus.

[8]  C. Ohyama,et al.  The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma. , 2019, European urology focus.

[9]  P. Pierorazio,et al.  Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma , 2018, The Journal of urology.

[10]  C. Ohyama,et al.  Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma. , 2017, European urology focus.

[11]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.

[12]  M. Babjuk,et al.  Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. , 2017, European urology.

[13]  M. Babjuk,et al.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[14]  K. Aben,et al.  Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study. , 2016, European journal of cancer.

[15]  M. Kaag,et al.  Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis. , 2016, The oncologist.

[16]  Y. Lotan,et al.  Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? , 2015, The Journal of urology.

[17]  Y. Lotan,et al.  A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. , 2015, The Journal of urology.

[18]  M. Jinzaki,et al.  Visceral to total obesity ratio and severe hydronephrosis are independently associated with prolonged pneumoperitoneum operative time in patients undergoing laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma , 2015, SpringerPlus.

[19]  V. Margulis,et al.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. , 2012, European urology.

[20]  K. Bensalah,et al.  Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. , 2012, The Journal of urology.

[21]  M. Stifelman,et al.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.

[22]  F. Ito,et al.  Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival , 2010, International journal of urology : official journal of the Japanese Urological Association.

[23]  R. Millikan,et al.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma , 2010, Cancer.

[24]  B. Lane,et al.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy , 2010, Cancer.

[25]  Y. Lotan,et al.  Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.

[26]  K. Bensalah,et al.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  N. Cowan,et al.  Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour , 2007, BJU international.

[28]  F. Ito,et al.  Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. , 2005, Urology.

[29]  H. Nishiyama,et al.  Evaluation for Surrogacy of End Points by Using Data from Observational Studies: Tumor Downstaging for Evaluating Neoadjuvant Chemotherapy in Invasive Bladder Cancer , 2006, Clinical Cancer Research.

[30]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.